By Iain Gilbert
Date: Wednesday 25 Feb 2026
(Sharecast News) - Drugmaker GSK has agreed to acquire Canadian clinical-stage biopharmaceutical firm 35Pharma for $950m in cash.
| Share Issuance for ICU Study Submission | 25-Feb-2026 | 07:00 | RNS |
| Haleon Preliminary 2025 Full Year Results | 25-Feb-2026 | 07:00 | RNS |
| GSK enters agreement to acquire 35Pharma | 25-Feb-2026 | 07:00 | RNS |
| Transaction in Own Shares | 25-Feb-2026 | 07:00 | RNS |
| Filing of Form 20-F with SEC | 25-Feb-2026 | 07:00 | RNS |
| Questor :GW Pharmaceuticals | 04-Dec-2014 | Telegraph |
| Questor : Hikma Pharmaceuticals | 13-Mar-2014 | Telegraph |
| Investment Column:BTG | 06-Oct-2011 | The Independent |
| Investment Column:Genus | 09-Sep-2011 | The Independent |
| Questor :Dechra Pharmaceuticals | 08-Sep-2011 | Telegraph |
| Price | 28,973.70 |
| Closing Price Change | -66.97 |
| % Change | -0.23 % |
| 24-Feb-26 Close | 28,973.70 |
You are here: research